A detailed history of Frazier Financial Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 17,135 shares of ABBV stock, worth $3.44 Million. This represents 2.63% of its overall portfolio holdings.

Number of Shares
17,135
Previous 17,105 0.18%
Holding current value
$3.44 Million
Previous $2.93 Billion 15.33%
% of portfolio
2.63%
Previous 2.33%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

BUY
$163.84 - $199.33 $4,915 - $5,979
30 Added 0.18%
17,135 $3.38 Billion
Q2 2024

Aug 12, 2024

BUY
$154.79 - $180.76 $13,621 - $15,906
88 Added 0.52%
17,105 $2.93 Billion
Q1 2024

May 13, 2024

SELL
$159.82 - $182.1 $166,852 - $190,112
-1,044 Reduced 5.78%
17,017 $3.1 Billion
Q4 2023

Feb 09, 2024

BUY
$137.6 - $154.97 $2.49 Million - $2.8 Million
18,061 New
18,061 $2.8 Billion

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $355B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Frazier Financial Advisors, LLC Portfolio

Follow Frazier Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Frazier Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frazier Financial Advisors, LLC with notifications on news.